Advertisement

Molecular Medicine

, Volume 21, Issue 1, pp 430–441 | Cite as

Modular Transcriptional Networks of the Host Pulmonary Response during Early and Late Pneumococcal Pneumonia

  • Brendon P. Scicluna
  • Miriam H. van Lieshout
  • Dana C. Blok
  • Sandrine Florquin
  • Tom van der Poll
Research Article

Abstract

Streptococcus pneumoniae (Spneu) remains the most lethal bacterial pathogen and the dominant agent of community-acquired pneumonia. Treatment has perennially focused on the use of antibiotics, albeit scrutinized due to the occurrence of antibiotic-resistant Spneu strains. Immunomodulatory strategies have emerged as potential treatment options. Although promising, immunomodulation can lead to improper tissue functions either at steady state or upon infectious challenge. This argues for the availability of tools to enable a detailed assessment of whole pulmonary functions during the course of infection, not only those functions biased to the defense response. Thus, through the use of an unbiased tissue microarray and bioinformatics approach, we aimed to construct a comprehensive map of whole-lung transcriptional activity and cellular pathways during the course of pneumococcal pneumonia. We performed genome-wide transcriptional analysis of whole lungs before and 6 and 48 h after Spneu infection in mice. The 4,000 most variable transcripts across all samples were used to assemble a gene coexpression network comprising 13 intercorrelating modules (clusters of genes). Fifty-four percent of this whole-lung transcriptional network was altered 6 and 48 h after Spneu infection. Canonical signaling pathway analysis uncovered known pathways imparting protection, including IL17A/IL17F signaling and previously undetected mechanisms that included lipid metabolism. Through in silico prediction of cell types, pathways were observed to enrich for distinct cell types such as a novel stromal cell lipid metabolism pathway. These cellular mechanisms were furthermore anchored at functional hub genes of cellular fate, differentiation, growth and transcription. Collectively, we provide a benchmark unsupervised map of whole-lung transcriptional relationships and cellular activity during early and late pneumococcal pneumonia.

Notes

Acknowledgments

We thank Joost Daalhuisen and Regina de Beer for expert technical assistance and the animal caretakers of the AMC animal research core facility.

References

  1. 1.
    O’Brien KL, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 374:893–902.CrossRefGoogle Scholar
  2. 2.
    Mandell LA, et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44:S27–S72.CrossRefGoogle Scholar
  3. 3.
    Ramirez JA, Anzueto AR. (2011) Changing needs of community-acquired pneumonia. J. Antimicrob. Chemother. 66(Suppl 3):iii3–iii9.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Viasus D, Garcia-Vidal C, Carratalà J. (2013) Advances in antibiotic therapy for community-acquired pneumonia. Curr. Opin. Pulm. Med. 19:209–215.CrossRefGoogle Scholar
  5. 5.
    van der Poll T, Opal SM. (2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 374:1543–1556.CrossRefGoogle Scholar
  6. 6.
    Kadioglu A, Weiser JN, Paton JC, Andrew PW. (2008) The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6:288–301.CrossRefGoogle Scholar
  7. 7.
    Hancock RE, Nijnik A, Philpott DJ. (2012) Modulating immunity as a therapy for bacterial infections. Nat. Rev. Microbiol. 10:243–254.CrossRefGoogle Scholar
  8. 8.
    Opitz B, van Laak V, Eitel J, Suttorp N. (2010) Innate immune recognition in infectious and noninfectious diseases of the lung. Am. J. Respir. Crit. Care Med. 181:1294–1309.CrossRefGoogle Scholar
  9. 9.
    Barabási AL. (2009) Scale-free networks: a decade and beyond. Science. 325:412–413.CrossRefGoogle Scholar
  10. 10.
    Brodsky IE, Medzhitov R. (2009) Targeting of immune signalling networks by bacterial pathogens. Nat. Cell Biol. 11:521–526.CrossRefGoogle Scholar
  11. 11.
    Dessing MC, Florquin S, Paton JC, van der Poll T. (2008) Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci. Cell. Microbiol. 10:237–246.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Lammers AJ, et al. (2011) Enhanced vulnerability for Streptococcus pneumoniae sepsis during asplenia is determined by the bacterial capsule. Immunobiology. 216:863–870.CrossRefGoogle Scholar
  13. 13.
    van Lieshout MH, Scicluna BP, Florquin S, van der Poll T. (2014) NLRP3 and ASC differentially affect the lung transcriptome during pneumococcal pneumonia. Am. J. Respir. Cell Mol. Biol. 50:699–712.CrossRefGoogle Scholar
  14. 14.
    Dunning MJ, Smith ML, Ritchie ME, Tavare S. (2007) beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23:2183–2184.CrossRefGoogle Scholar
  15. 15.
    Gentleman RC, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80.CrossRefGoogle Scholar
  16. 16.
    Shi W, Oshlack A, Smyth GK. (2010) Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips. Nucleic Acids Res. 38:e204.CrossRefGoogle Scholar
  17. 17.
    Kauffmann, A, et al. (2009) Importing ArrayExpress datasets into R/Bioconductor. Bioinformatics. 25:2092–2094.CrossRefGoogle Scholar
  18. 18.
    Barbosa-Morais NL, et al. (2010) A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res. 38:e17.CrossRefGoogle Scholar
  19. 19.
    Smyth GK. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3.CrossRefGoogle Scholar
  20. 20.
    Benjamini Y, Hochberg Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57:289–300.Google Scholar
  21. 21.
    Langfelder P, Horvath S. (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 9:559.CrossRefGoogle Scholar
  22. 22.
    Zhang B, Horvath S. (2005) A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4:17.CrossRefGoogle Scholar
  23. 23.
    Langfelder P, Zhang B, Horvath S. (2008) Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24:719–720.CrossRefGoogle Scholar
  24. 24.
    Jonczyk MS, et al. (2014) Genetic factors regulating lung vasculature and immune cell functions associate with resistance to pneumococcal infection. PLoS One. 9:e89831.CrossRefGoogle Scholar
  25. 25.
    Shannon P, et al. (2003) Cytoscape: a software environment 441 for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504.CrossRefGoogle Scholar
  26. 26.
    Heng TS, Painter MW; Immunological Genome Project Consortium. (2008) The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9:1091–1094.CrossRefGoogle Scholar
  27. 27.
    Chen J, Bardes EE, Aronow BJ, Jegga AG. (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37:W305–W311.CrossRefGoogle Scholar
  28. 28.
    Kasprzyk A (2011) BioMart: driving a paradigm change in biological data management. Database 2011:bar049.CrossRefGoogle Scholar
  29. 29.
    Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. (2004) A global test for groups of genes: testing association with a clinical outcome. Bioinformatics. 20:93–99.CrossRefGoogle Scholar
  30. 30.
    Ravaz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL (2002). Hierarchical organization of modularity in metabolic networks. Science. 297:1551–1555.CrossRefGoogle Scholar
  31. 31.
    Scicluna BP, et al. (2013) Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome. PLoS One. 8:e79051.CrossRefGoogle Scholar
  32. 32.
    Horvath S, et al. (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl. Acad. Sci. U. S. A. 103:17402–17407.CrossRefGoogle Scholar
  33. 33.
    Oldham MC, et al. (2008) Functional organization of the transcriptome in human brain. Nat. Neurosci. 11:1271–1282.CrossRefGoogle Scholar
  34. 34.
    Scott MG, et al. (2007) An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25:465–472.CrossRefGoogle Scholar
  35. 35.
    Tsai HC, Velichko S, Hung LY, Wu R. (2013) IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. Clin. Dev. Immunol. 2013:267971.Google Scholar
  36. 36.
    Wang WY, Lim JH, Li JD. (2012) Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections. Cell. Mol. Immunol. 9:131–135.CrossRefGoogle Scholar
  37. 37.
    Bruyn GA, Zegers BJ, van Furth R. (1992) Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin. Infect. Dis. 14:251–262.CrossRefGoogle Scholar
  38. 38.
    Lizak M, Yarovinsky TO. (2012) Phospholipid scramblase 1 mediates type i interferon-induced protection against staphylococcal α-toxin. Cell Host Microbe. 11:70–80.CrossRefGoogle Scholar
  39. 39.
    Hayden MS, Ghosh S. (2011) NF-κB in immunobiology. Cell Res. 21:223–244.CrossRefGoogle Scholar
  40. 40.
    Schneider DS, Ayres JS. (2008) Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8:889–895.CrossRefGoogle Scholar
  41. 41.
    Råberg L, Sim D, Read AF. (2007) Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science. 318:812–814.CrossRefGoogle Scholar
  42. 42.
    Gordon S. (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:927–930.CrossRefGoogle Scholar
  43. 43.
    Jenkins SJ, Hume DA. (2014) Homeostasis in the mononuclear phagocyte system. Trends Immunol. 35:358–367.CrossRefGoogle Scholar
  44. 44.
    Scotet E, Nedellec S, Devilder MC, Allain S, Bonneville M. (2008) Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk. Front. Biosci. 13:6872–6885.CrossRefGoogle Scholar
  45. 45.
    Hsieh CC, et al. (2013) The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood. 121:1760–1768.CrossRefGoogle Scholar
  46. 46.
    Lalli PN, et al. (2008) Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood. 112:1759–1766.CrossRefGoogle Scholar
  47. 47.
    Strainic MG, et al. (2008) Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity. 28:425–435.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2015

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Brendon P. Scicluna
    • 1
  • Miriam H. van Lieshout
    • 1
  • Dana C. Blok
    • 1
  • Sandrine Florquin
    • 2
  • Tom van der Poll
    • 1
    • 3
  1. 1.Center for Experimental Molecular Medicine and Center for Infection and Immunity AmsterdamUniversity of AmsterdamAmsterdamThe Netherlands
  2. 2.Department of Pathology, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  3. 3.Division of Infectious Diseases, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands

Personalised recommendations